INFORMACIÓN IMPORTANTE SELECCIONADA: No debe utilizar KOVALTRY® si es alérgico a los roedores (como ratones y hámsteres) o a cualquier ingrediente de KOVALTRY® SIGA LEYENDO A CONTINUACIÓN  >

KOVALTRY® Conversations: Real patients talking about living with hemophilia A and treatment with KOVALTRY®

 

KOVALTRY® Conversations: Real patients talking about living with hemophilia A and treatment with KOVALTRY®

 

Product choice is a decision that should be based on an individual's needs. These are some stories of patients using KOVALTRY®, but everyone's experience is different. Consult with your healthcare provider to see if KOVALTRY® is right for you.

Shariff share buttons

Shariff share buttons

Join the Conversation!
Want to share your patient or caregiver story?
Let us know if you would like to be contacted—your experiences could be featured in KOVALTRY® Conversations.
Register to share your story

INDICATIONS

KOVALTRY®  is a medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A.

KOVALTRY® is used to treat and control bleeding in adults and children with hemophilia A.KOVALTRY® can reduce the number of bleeding episodes in adults and children with hemophilia A when used regularly (prophylaxis). Your healthcare provider may give you KOVALTRY® when you have surgery.

KOVALTRY® is not used to treat von Willebrand Disease.

IMPORTANT SAFETY INFORMATION

You should not use KOVALTRY® if you are allergic to rodents (like mice and hamsters) or any ingredients in KOVALTRY®.

Tell your healthcare provider if you have heart disease or are at risk for heart disease.

The common side effects of KOVALTRY® are headache, fever, and itchy rash, in addition to inhibitors in patients who were not previously treated or minimally treated with Factor VIII products.

Your body can also make antibodies, called "inhibitors," against KOVALTRY®, which may stop KOVALTRY® from working properly. If your bleeding is not adequately controlled, it could be due to the development of Factor VIII inhibitors.Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to Factor VIII.

Allergic reactions may occur with KOVALTRY®. Call your healthcare provider right away and stop treatment if you get tightness of the chest or throat, dizziness, decrease in blood pressure, and nausea.

Tell your healthcare provider about any side effect that bothers you or that does not go away.

Call your healthcare provider right away if bleeding is not controlled after using KOVALTRY®.

For additional important risk and use information, please see full Prescribing Information.